Published in Am J Cardiol on June 15, 2009
Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol (2011) 1.12
Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev (2012) 1.06
Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag (2011) 1.01
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events. Circ Heart Fail (2012) 0.97
BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail Rev (2014) 0.90
The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev (2012) 0.89
Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol (2012) 0.88
Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Fail Rev (2011) 0.83
NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study. PLoS One (2013) 0.82
miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. J Mol Cell Cardiol (2013) 0.82
Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome. Int J Nephrol (2011) 0.81
ADPKD: Prototype of Cardiorenal Syndrome Type 4. Int J Nephrol (2010) 0.81
Novel renal biomarkers to assess cardiorenal syndrome. Curr Heart Fail Rep (2014) 0.80
The multi-biomarker approach for heart failure in patients with hypertension. Int J Mol Sci (2015) 0.78
Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol (2011) 0.78
Cardiorenal Syndrome Type 1: Renal Dysfunction in Acute Decompensated Heart Failure. J Clin Outcomes Manag (2015) 0.77
Assessing Risk and Preventing 30-Day Readmissions in Decompensated Heart Failure: Opportunity to Intervene? Curr Heart Fail Rep (2015) 0.75
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Lancet (2013) 2.81
Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv (2011) 2.67
[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Rev Esp Cardiol (2006) 2.63
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol (2005) 2.47
Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol (2012) 2.32
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv (2012) 2.07
Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail (2011) 1.92
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol (2008) 1.89
Mental health surveillance among children--United States, 2005-2011. MMWR Surveill Summ (2013) 1.88
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J (2008) 1.75
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol (2013) 1.72
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol (2011) 1.67
[Clinical utilization of the coronary pressure wire]. Rev Esp Cardiol (2002) 1.56
Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure. Rev Esp Cardiol (Engl Ed) (2012) 1.49
Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome. Rev Esp Cardiol (Engl Ed) (2011) 1.46
Pulmonary surfactant protein B in the peripheral circulation and functional impairment in patients with chronic heart failure. Rev Esp Cardiol (2009) 1.46
[Intracoronary stem cell transplantation in acute myocardial infarction]. Rev Esp Cardiol (2004) 1.44
Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting. Thromb Haemost (2011) 1.43
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41
Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy? Rev Esp Cardiol (2009) 1.41
Characteristics of sudden death in inherited heart disease. Rev Esp Cardiol (2010) 1.39
[Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure]. Rev Esp Cardiol (2011) 1.39
[Troponin-T monitoring in outpatients with nonischemic heart failure]. Rev Esp Cardiol (2008) 1.39
[A comparative study of patients with methicillin susceptible versus methicillin resistant Staphylococcus aureus bacteremia: epidemiology and prognostic factors]. Med Clin (Barc) (2007) 1.39
[Direct Stenting without Predilation: a Single-Center Experience with 1,000 Lesions]. Rev Esp Cardiol (2002) 1.39
Influence of aortic regurgitation after TAVI on left ventricular filling pattern. Eur J Clin Invest (2015) 1.38
Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol (2009) 1.35
Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem (2003) 1.28
Brugada-like electrocardiographic pattern induced by fever. Pacing Clin Electrophysiol (2002) 1.15
[Use of a coronary risk score (the TIMI Risk Score) in a non-selected patient population assessed for chest pain at an emergency department]. Rev Esp Cardiol (2005) 1.13
Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J (2004) 1.12
Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res (2010) 1.08
[Short- and medium-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease in patients who are poor candidates for surgical revascularization]. Rev Esp Cardiol (2004) 1.07
[Program of coronary angioplasty in acute myocardial infarction in the region of Murcia (Spain). APRIMUR Registry]. Rev Esp Cardiol (2002) 1.07
[Time intervals in primary angioplasty from onset of symptoms until restoration of blood flow]. Rev Esp Cardiol (2002) 1.07
Cross talk between a fungal blue-light perception system and the cyclic AMP signaling pathway. Eukaryot Cell (2006) 1.04
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol (2013) 1.02
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost (2013) 1.02
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol (2012) 0.97
Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis (2013) 0.97
Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol (2003) 0.97
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J (2008) 0.95
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J (2009) 0.94
β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol (2011) 0.93
Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail (2010) 0.93
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med (2011) 0.92
A new approach to hand-assisted laparoscopic liver surgery. Surg Endosc (2008) 0.92
Cholinesterase activity of human lung tumours varies according to their histological classification. Carcinogenesis (2005) 0.92
An atypical presentation of Tako-Tsubo cardiomyopathy. Int J Cardiol (2008) 0.90
Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system. Free Radic Biol Med (2011) 0.90
Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005). Rev Iberoam Micol (2009) 0.90
Association between diagnosed ADHD and selected characteristics among children aged 4-17 years: United States, 2011-2013. NCHS Data Brief (2015) 0.89
Reproducibility of echocardiographic measurements of epicardial fat thickness. Int J Cardiol (2008) 0.89
High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg (2013) 0.89
Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3. Heart (2010) 0.89
Ependymal cell differentiation and GLUT1 expression is a synchronous process in the ventricular wall. Neurochem Res (2005) 0.88
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol (Engl Ed) (2012) 0.87
Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic. Am J Cardiol (2009) 0.87
[Clinical and Preclinical Heart Failure Research Network (REDINSCOR). Instituto de Salud Carlos III Cooperative Special Topic Research Networks]. Rev Esp Cardiol (2008) 0.86
Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol (2010) 0.86
Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congest Heart Fail (2010) 0.86
Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb Haemost (2009) 0.86
Unusual presentation of acute coronary syndrome. Bilateral coronary dissection after car accident. Am J Emerg Med (2009) 0.84
β-Trace protein: from GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol (2013) 0.84
Soluble ST2 is a marker for acute cardiac allograft rejection. Ann Thorac Surg (2011) 0.84
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. Int J Cardiol (2008) 0.83
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. Chest (2008) 0.83
Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circ Cardiovasc Interv (2013) 0.83
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail (2008) 0.83
Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy. J Renin Angiotensin Aldosterone Syst (2011) 0.82
Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke (2014) 0.82
Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J (2012) 0.82
Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci (Lond) (2008) 0.81
Sex hormone-binding globulin: a new marker of disease severity and prognosis in men with chronic heart failure. Rev Esp Cardiol (2009) 0.81
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. Eur Heart J (2009) 0.81
Involvement of ferritin heavy chain in the preventive effect of metformin against doxorubicin-induced cardiotoxicity. Free Radic Biol Med (2012) 0.81
Observational study of lipid profile and LDL particle size in patients with metabolic syndrome. Lipids Health Dis (2011) 0.81
The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review. Eur J Clin Invest (2013) 0.80
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation. Eur J Clin Invest (2012) 0.80
β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. Chest (2013) 0.80
The prognostic role of the adiponectin levels in atrial fibrillation. Eur J Clin Invest (2012) 0.80
Prognostic value of the Thrombolysis in Myocardial Infarction risk score in a unselected population with chest pain. Construction of a new predictive model. Am J Emerg Med (2008) 0.80
Short-term variability of heart rate turbulence in chronic heart failure. J Card Fail (2011) 0.80
Heat stroke, an unusual trigger of Brugada electrocardiogram. Am J Emerg Med (2009) 0.80
Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism. Brain Res (2007) 0.79
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. Br J Haematol (2014) 0.79
Typical and atypical stem cells in the brain, vitamin C effect and neuropathology. Biol Res (2012) 0.79
[Usefulness of high sensitivity troponin T assay in detecting acute allograft rejection after heart transplantation]. Rev Esp Cardiol (2011) 0.79
[The frequency of systolic aortic regurgitation and its relationship to heart failure in a consecutive series of patients]. Rev Esp Cardiol (2008) 0.79
Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery. Mini Rev Med Chem (2012) 0.79
Acetylcholinesterase biogenesis is impaired in lung cancer tissues. Chem Biol Interact (2005) 0.79